|
Dr. Bauer, the Chairman of the Board and a director of Modigene, is the Chief Executive Officer of Neosil, Inc., an early stage dermatology pharmaceutical company, and Professor Emeritus in the School of Medicine at Stanford University.
Dr. Bauer is one of three co-founders and emeritus member of the Board of Directors of Connetics Corporation, a company focused on pharmaceuticals for skin diseases that has grown to have a market capitalization of over $1 billion. He is also a member of the Board of Directors of Neosil, Inc., Protalex, Inc., and Echo Healthcare Acquisition Corp. He has served on several not-for-profit boards of directors, including the boards of directors of Stanford Hospital and Clinics, the Lucile Salter Packard Children's Hospital, and UCSF Stanford Health Care, and is currently on the Board of Directors of the American Dermatological Association.
Since 2003, Dr. Bauer has been a Senior Client Partner for the North American Health Care Division of Korn/Ferry International. From 2002 to 2003, Dr. Bauer was a Senior Consultant for this same division.
Dr. Bauer served as Vice President for Medical Affairs of Stanford University from 1997 to 2001, and as Dean of the School of Medicine from 1995 to 2001. In these positions, Dr. Bauer was responsible on behalf of Stanford University for all financial and strategic activities of the School of Medicine, the Stanford University Hospital, the Faculty Practice and the Lucile Packard Children's Hospital. In the aggregate, the annual budgets of these four entities approximated $1.5 billion. Dr. Bauer has been a professor at Stanford University since 1988. Dr. Bauer received his B.S. from Northwestern University in 1964 and his M.D. from Northwestern University Medical School in 1967. He is the member of many honorific societies, inculding the Institute of Medicine of the National Academy of Sciences. | 